Moonshot Foundry Fund

🔴 Problem Identified

European venture capital has shifted from funding high-risk, innovative startups to focusing on safer, revenue-driven businesses, resembling small-cap private equity. This 'Safe Bet Syndrome' prioritizes predictable returns over breakthrough technologies, leading to decreased funding for transformative innovation. Consequently, a funding gap has emerged, leaving academic discoveries undercapitalized and limiting Europe's ability to produce groundbreaking technologies. The current VC model's short-term, risk-averse approach contrasts with past eras of rapid tech advancement fueled by patient, risk-tolerant capital. To revive true innovation, Europe needs new investment institutions with long horizons willing to back high-risk, high-reward projects.

💡 Proposed Solution

Create a specialized investment platform combining an evergreen “patient capital” fund (15-20 year cycle) with a network of technical, IP, and commercialization mentors focused on academic spinouts and high-risk deep tech ventures. The platform scouts and vets projects in partnership with universities, provides funding tranches linked to technical milestones, and supports ventures with regulatory, technical, and business development resources. This institutional approach pools risk and attracts...

Register to read the full solution →